Celebrex - Bextra Mobicox Class Action

A Celebrex/Bextra/Mobicox Class Action was launched by Merchant Law Group in October 2004 against drug company giant Pfizer. Merchant Law Group LLP is reported by major media outlets, including CNN, to be the first law firm in North America to launch a proposed Class Action on behalf of Celebrex , Bextra and Mobicox users.

Merchant Law Group LLP has 12 offices across Canada, with lawyers practising law in six provinces and an American state. Tony Merchant, Q.C., and his firm are well known for their involvement in Mass & Class Action cases in Canada, including class proceedings regarding Complete Contact Lens Solution, Silicon Breast Implant, Winners/HomeSense, HSBC Mutual Funds, Various Cellular Phone Fees, Molson-Coors Merger, Conrad Black/Hollinger, GM Gasket Manifolds, Lead Paint in Toys (and similar consumer products), Menu Foods, Paxil, Vioxx, Agent Orange, Métis Veteran Benefits, Cryptosporidium Water, Sony, Residential School litigation, CPR Anhydrous Ammonia, and cases regarding ISM Information Security, Tundra noxious gas emissions, Zonolite, Canadian Wheat Board Pool transfers, and various other cases. Tony Merchant is known to be one of Canada’s most active litigators with more than 600 reported cases in leading Caselaw Journals, having argued thousands of cases before the Canadian and American Courts, in Trial and Administrative Courts, and the Courts of Appeal of various American and Canadian jurisdictions, the Federal Court of Canada, and the Supreme Court of Canada. Tony Merchant, Q.C., has a long history in pursuing public policy cases and is a former Member of the Legislative Assembly (M.L.A.).

Related articles